Eltrombopag Choline is a thrombopoietin receptor agonist indicated for the treatment of chronic immune thrombocytopenia in adult patients who have not responded sufficiently to other therapies or splenectomy.… Read more
Eltrombopag Choline is a thrombopoietin receptor agonist indicated for the treatment of chronic immune thrombocytopenia in adult patients who have not responded sufficiently to other therapies or splenectomy. This therapeutic agent is also utilized to manage thrombocytopenia in patients with chronic hepatitis C, facilitating the initiation and maintenance of interferon-based treatments. This category offers high-quality reference standards for Eltrombopag Choline, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and routine quality control of the drug substance. By utilizing these precise analytical tools, researchers can ensure compliance with regulatory standards and maintain the integrity of their drug development and manufacturing processes throughout the product lifecycle.